骨转移放疗方案选择应考量患者与疾病特征
该回顾性研究分析了475例骨转移放疗患者,发现原发肿瘤类型和KPS显著影响总生存,年龄在部分原发肿瘤中也有意义;疼痛控制不受原发肿瘤类型或BED显著影响,短疗程与长疗程止痛效果相当。
要点
- 原发肿瘤类型和KPS是骨转移放疗患者生存的显著影响因素。
- 疼痛控制不受原发肿瘤类型或BED显著影响。
- 短疗程与长疗程放疗在止痛效果上相当。
核心结论
- 选择骨转移放疗分割方案应综合考虑原发肿瘤类型、KPS和年龄。
- 短疗程放疗在疼痛控制方面与长疗程同样有效,且不受原发肿瘤类型影响。
研究设计与样本
- 回顾性分析2009至2014年单中心475例接受骨转移放疗的患者。
- 采用Kaplan-Meier分析总生存,递归分割分析(RPA)生成决策树,Cox模型验证RPA并评估BED等因素的显著性。
主要发现
- 中位年龄62岁,中位KPS 70。
- 按原发肿瘤类型的中位生存时间:乳腺癌35.9个月、前列腺癌12.8个月、其他11.0个月、肺癌5.3个月、胃肠道癌4.0个月(P < .0001)。
- 原发肿瘤类型和KPS显著影响生存,年龄在某些原发肿瘤类型中也显著影响生存。
- 疼痛控制不受原发肿瘤类型(P = .72)或BED(P = .14)显著影响。
关键数值与推荐
- 原发肿瘤类型与生存显著相关(P < .0001)。
- 疼痛控制与原发肿瘤类型无关(P = .72),与BED无关(P = .14)。
临床怎么用
- 制定骨转移放疗分割方案时应评估原发肿瘤类型、KPS和年龄。
- 可参考本研究生成的RPA模型辅助决策。
- 对于疼痛控制,可考虑使用短疗程方案,其效果与长疗程相当。
局限性
- 回顾性单中心研究,结果需外部验证。
- 原文未报告RPA模型的具体分层阈值与风险分组细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation therapy is one of the mainstays of treatment for painful bone metastases; however, the optimal fractionation and dosing of radiation for a given patient and disease characteristics are still subject to debate. METHODS AND MATERIALS: We retrospectively examined 475 patients who received radiation for bone metastases at our institution from 2009 through 2014 and evaluated survival outcomes based on parameters of their first treatment course and patient demographics. Kaplan-Meier analysis was used to analyze factors associated with overall survival (OS). A recursive partition analysis (RPA) was used to generate a decision tree of patient characteristics resulting in significant differences in survival. A Cox model was used to verify the RPA and evaluate the significance of biologically equivalent dose (BED) along with other factors. RESULTS: In our cohort, median age was 62 years and median Karnofsky performance status (KPS) was 70. Survival time by primary tumor type: breast (median, 35.9 months), prostate (12.8 months), other (median, 11.0 months), lung (median, 5.3 months), and gastrointestinal (median, 4.0 months) (P < .0001). Primary tumor type and KPS significantly affected survival, whereas age was also significant for survival in certain primary tumor types. Pain control was not found to be significantly affected by primary tumor type (P = .72) or BED (P = .14). CONCLUSION: Our data demonstrate that selection of radiation fractionation schedules should take into account primary tumor type, KPS, and age, and we have generated an RPA model including these factors to help guide decision making. We also found that shorter fractionation schedules are as effective as longer fractionation schedules for pain control, regardless of primary tumor type.
引用
- Liu Y, von Eyben R, Kidd EA, et al. Consideration of patient and disease characteristics in selecting radiation regimens for treatment of bone metastases. Pract Radiat Oncol. 2017. PMID: 28751228. doi:10.1016/j.prro.2017.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。